Skip to main content
Fig. 3 | Chemistry Central Journal

Fig. 3

From: Application of a strategy based on metabolomics guided promoting blood circulation bioactivity compounds screening of vinegar

Fig. 3

a Effects of RV and WV on antiplatelet in vitro (1 Aspirin group; 2 2–3 year aging processed RV group; 3 1–2 year aging processed RV group; 4 0–1 year aging processed RV group; 5 WV group; 6 Control group); b alkaloids metabolites of different vinegar inhibition of AA induced platelet aggregation in vitro (1 Aspirin group; 2 Alkaloids metabolites of 2–3 year aging processed RV; 3 Alkaloids metabolites of 1–2 year aging processed RV; 4 Alkaloids metabolites of 0–1 year aging processed RV; 5 Alkaloids metabolites of WV; 6 Control group); c AUC value of different vinegars inhibition of ADP induced platelet aggregation in vitro; d AUC value of alkaloids metabolites of different vinegar inhibition of AA induced platelet aggregation in vitro. ‘*’ and ‘**’, p < 0.05 and p < 0.01 respectively, comparison with the normal control group

Back to article page